Midline IV replacements under the microscope: a hospital study

NCT ID NCT07394296

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks nearly 1,000 hospital patients who get a midline IV, a type of intravenous line used for treatments lasting up to 28 days. Researchers want to see how often these lines need to be replaced or removed early, and why. The goal is to help doctors choose the best IV device for each patient, reducing complications and improving care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help hospitals choose the right IV device for each patient, reducing unnecessary replacements and complications.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve patient outcomes. Results may vary across hospitals and may not apply to all settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMPROVE THE MANAGEMENT OF MIDLINES AFTER PLACEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier de Valenciennes

    RECRUITING

    Valenciennes, 59300, France

    Contact